Ledger.Open graph →
SEC Form D · filed March 1, 2023

Ensysce Biosciences, Inc

Offering
$2.8M
Sold
$2.8M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
LA JOLLA, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (26)

Andrew L. Benton · La Jolla, CADirectorLee L. Rauch · La Jolla, CADirectorBob L. Gower · La Jolla, CADirectorWilliam L. Chang · La Jolla, CADirectorCurtis L. Rosebraugh · La Jolla, CADirectorAdam L. Levin · La Jolla, CADirectorSteve L. Martin · La Jolla, CADirectorDavid L. Humphrey · La Jolla, CAExecJohn Levin · New York, NYDirectorEdward Giordano · New York, NYExecChristopher Flynn · Boston, MADirectorJames Fellows · New York, NYDirectorMichael Cardamone · NEW YORK, NYDirectorJared Kleinert · NEW YORK, NYDirectorTelmo Martins · Chicago, ILDirectorSabrina Rusnak-Carlson · Boston, MADirectorD L. Kirkpatrick · La Jolla, CAExec · DirectorOliver Bell · Road Town, British Virgin IslandsExecPhilip Cater · George Town, Cayman IslandsDirectorThomas Chladek · Baar, V8DirectorAdmire Chatiza · London, United KingdomDirectorJoshua M. Hile · Issaquah, WADirectorJeffrey B. Miller · New Athens, ILDirectorMartin Pawlik · New York, NYDirectorBenjamin Lyons · Raleigh, NCDirectorD L. Kirkpatrick · La Jolla, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗